Page last updated: 2024-11-03

probenecid and Adenocarcinoma

probenecid has been researched along with Adenocarcinoma in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gibbs, JP1
Adeyeye, MC1
Yang, Z1
Shen, DD1
Kaufman, A1
Hilaski, S1
DiVasto, P1
VanderMeer, J1
Eppler, B1

Other Studies

2 other studies available for probenecid and Adenocarcinoma

ArticleYear
Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.
    Epilepsy research, 2004, Volume: 58, Issue:1

    Topics: Adenocarcinoma; Animals; Biological Transport, Active; Brain; Cattle; Cells, Cultured; Cyclooxygenas

2004
Total health needs of the rape victim.
    The Journal of family practice, 1975, Volume: 2, Issue:3

    Topics: Abortion, Therapeutic; Adenocarcinoma; Adult; Affective Symptoms; Ampicillin; Diethylstilbestrol; Ec

1975